专注于安达提交的第一阶段审批:了解常见缺陷和案例研究见解
Jyoti Pawar1, Namita Hegde1, Sanjay Sharma2
1Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management SVKM's NMIMS, V. L. Mehta Road, Vile Parle (W), Mumbai, 400056, India.
Therapeutic innovation & regulatory science
|February 8, 2025
概括
仿制药公司可以通过解决缩写新药申请 (ANDA) 的常见缺陷来提高第一周期批准率. 这包括加强数据提交,制造,标签,药物主档 (DMF) 要求和生物等价性研究.
科学领域:
- 制药科学 制药科学
- 监管事务 监管事务
- 药物开发 药物开发
背景情况:
- 缩写新药申请 (ANDA) 的第一周期批准对于通用药物进入市场至关重要.
- 在ANDA提交中经常出现的缺陷导致审查延迟和多个周期.
- 了解这些缺陷是优化仿制药批准过程的关键.
研究的目的:
- 确定ANDA提交的常见缺陷领域.
- 分析这些缺陷对批准时间表的影响.
- 为改善第一周期审批率提供指导.
主要方法:
- 基于文献的行业报告,监管指南和发表文章的分析.
- 对缩写新药申请 (ANDA) 缺陷趋势的审查.
- 对缺陷对批准时间表的影响的案例研究分析.
主要成果:
- 关键缺陷领域包括不完整的数据,不充分的制造工艺,标签问题和药物主文件 (DMF) 的不合规.
- 生物等价性研究不足是一个重大障碍.
- 这些缺陷往往导致延长审查期.
结论:
- 通过解决发现的缺陷来完善ANDA提交,可以提高第一周期批准的成功率.
- 为仿制药开发商提供实用指导,使其与食品和药物管理局 (FDA) 的标准保持一致.
- 优化提交导致仿制药更快地进入市场.
更多相关视频
相关概念视频
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Preclinical Development: Overview
4.2K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.2K
Pharmacovigilance
769
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
769
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
114
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
114
Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K


